Product
XON7
1 clinical trial
2 indications
Indication
Advanced Solid TumorIndication
Metastatic CancerClinical trial
Phase I/II, Multi Center, Open Label, First-in-human, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, and Anti-tumors Efficacy of the Glyco-humanized Polyclonal Antibody XON7 in Patients With Advanced or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2026-12-01